Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples (MS-NANOSE)

This study has been completed.
Sponsor:
Collaborator:
Technion, Israel Institute of Technology
Information provided by (Responsible Party):
Ariel Miller, Carmel Medical Center
ClinicalTrials.gov Identifier:
NCT01206023
First received: September 19, 2010
Last updated: June 26, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)